Cancer Prevention Pharmaceutical Company – Has Accepted Offer

Price: $20,000,000

Annual Revenue: $5,696,380

Net Cash Flow: $3,000,942

Industry: Health Care, Pharmaceutical

Company provides an FDA approved drug product which is proven to safely and effectively prevent a specific type of cancer. Tremendous opportunities exist with very large up-side potential. Extremely low overhead, asset light and can be run from any location. Uniquely insulated from any competitive threat or chance of obsolescence.

Growth and Expansion:
Company currently has two owners who dedicate a few hours per day to its operation. Following a sale, one owner desires to remain with company as an employee. All production, packaging and distribution is contracted to third parties with redundancies. Company primarily focuses on its domestic market and has no formal marketing or business development function. Pricing has not increased in 15 years and demand for its product is price inelastic.

Competition:
FDA Approval insulates company from competition. Enjoys monopoly-like market positioning.
Growth & Expansion:
Tremendous upside by raising prices, developing sales and marketing function and international markets.
Reason for Selling:
Retirement

Location

Relocatable?: Yes